The role of junctional adhesion molecules in vascular inflammation (Q36831671)

Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules

31 March 2020

1 reference

The JAM family of junctional adhesion molecules

31 March 2020

1 reference

Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration

31 March 2020

1 reference

Identification and characterisation of human Junctional Adhesion Molecule (JAM)

31 March 2020

1 reference

Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells

31 March 2020

1 reference

A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions

31 March 2020

1 reference

JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells

31 March 2020

1 reference

Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor

31 March 2020

1 reference

Vascular endothelial-junctional adhesion molecule (VE-JAM)/JAM 2 interacts with T, NK, and dendritic cells through JAM 3

31 March 2020

1 reference

JAM4, a junctional cell adhesion molecule interacting with a tight junction protein, MAGI-1

31 March 2020

1 reference

JAML, a novel protein with characteristics of a junctional adhesion molecule, is induced during differentiation of myeloid leukemia cells

31 March 2020

1 reference

X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif

31 March 2020

1 reference

Crystal structure of human junctional adhesion molecule 1: Implications for reovirus binding

31 March 2020

1 reference

Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration

31 March 2020

1 reference

The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1

31 March 2020

1 reference

Junctional adhesion molecule-C regulates the early influx of leukocytes into tissues during inflammation

31 March 2020

1 reference

Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin

31 March 2020

1 reference

The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM)

31 March 2020

1 reference

JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration

31 March 2020

1 reference

The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity

31 March 2020

1 reference

JAM-C regulates tight junctions and integrin-mediated cell adhesion and migration

31 March 2020

1 reference

JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes

31 March 2020

1 reference

Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-alpha plus interferon-gamma Does not reduce leukocyte transmigrati

31 March 2020

1 reference

Signaling through JAM-1 and αvβ3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and αvβ3 complex

31 March 2020

1 reference

The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment

31 March 2020

1 reference

Involvement of JAM-A in mononuclear cell recruitment on inflamed or atherosclerotic endothelium: inhibition by soluble JAM-A.

31 March 2020

1 reference

Identification of differential protein expression associated with development of unstable human carotid plaques

31 March 2020

1 reference

The F11 receptor (F11R/JAM-A) in atherothrombosis: overexpression of F11R in atherosclerotic plaques

31 March 2020

1 reference

Junctional adhesion molecule-A deficiency increases hepatic ischemia-reperfusion injury despite reduction of neutrophil transendothelial migration

31 March 2020

1 reference

Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members

31 March 2020

1 reference

Homophilic interaction of junctional adhesion molecule.

31 March 2020

1 reference

The homophilic binding of junctional adhesion molecule-C mediates tumor cell-endothelial cell interactions

31 March 2020

1 reference

Dual interaction of JAM-C with JAM-B and alpha(M)beta2 integrin: function in junctional complexes and leukocyte adhesion

31 March 2020

1 reference

Endothelial tight junctions: permeable barriers of the vessel wall

31 March 2020

1 reference

Junctional adhesion molecule 1 regulates epithelial cell morphology through effects on beta1 integrins and Rap1 activity.

31 March 2020

1 reference

Involvement of the junctional adhesion molecule-1 (JAM1) homodimer interface in regulation of epithelial barrier function.

31 March 2020

1 reference

Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts

31 March 2020

1 reference

Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM).

31 March 2020

1 reference

Antibodies to the junctional adhesion molecule cause disruption of endothelial cells and do not prevent leukocyte influx into the meninges after viral or bacterial infection.

31 March 2020

1 reference

Importance of Junctional Adhesion Molecule-A for Neointimal Lesion Formation and Infiltration in Atherosclerosis-Prone Mice

31 March 2020

1 reference

The junctional adhesion molecule-C promotes neutrophil transendothelial migration in vitro and in vivo

31 March 2020

1 reference

The functional interaction of the beta 2 integrin lymphocyte function-associated antigen-1 with junctional adhesion molecule-A is mediated by the I domain

31 March 2020

1 reference

Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin alpha v beta 3 specific.

31 March 2020

1 reference

The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin

31 March 2020

1 reference

JAM2 interacts with alpha4beta1. Facilitation by JAM3

31 March 2020

1 reference

Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigration

31 March 2020

1 reference

The three-dimensional structure of integrins and their ligands, and conformational regulation of cell adhesion

31 March 2020

1 reference

A talin-dependent LFA-1 focal zone is formed by rapidly migrating T lymphocytes.

31 March 2020

1 reference

Junctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia-reperfusion injury.

31 March 2020

1 reference

Platelets as immune cells: bridging inflammation and cardiovascular disease

31 March 2020

1 reference

Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium

31 March 2020

1 reference

Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor

31 March 2020

1 reference

Increased DC trafficking to lymph nodes and contact hypersensitivity in junctional adhesion molecule-A-deficient mice

31 March 2020

1 reference

Fibroblast growth factor-2 failed to induce angiogenesis in junctional adhesion molecule-A-deficient mice

31 March 2020

1 reference

Essential role of junctional adhesion molecule-1 in basic fibroblast growth factor-induced endothelial cell migration.

31 March 2020

1 reference

Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth

31 March 2020

1 reference

Junctional adhesion molecule-C promotes metastatic potential of HT1080 human fibrosarcoma

31 March 2020

1 reference

Adhesion molecules in liver ischemia and reperfusion

31 March 2020

1 reference

Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease

31 March 2020

1 reference

Inflammation, atherosclerosis, and coronary artery disease

31 March 2020

1 reference

Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).

31 March 2020

1 reference

Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1.

31 March 2020

1 reference

Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

31 March 2020

1 reference

RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium.

31 March 2020

1 reference

A transmembrane tight junction protein selectively expressed on endothelial cells and platelets

31 March 2020

1 reference

ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability

31 March 2020

1 reference

The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction

31 March 2020

1 reference

Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells

31 March 2020

1 reference

The coxsackievirus and adenovirus receptor interacts with the multi-PDZ domain protein-1 (MUPP-1) within the tight junction

31 March 2020

1 reference

Coxsackievirus and adenovirus receptor (CAR) is expressed in male germ cells and forms a complex with the differentiation factor JAM-C in mouse testis

31 March 2020

1 reference